318 related articles for article (PubMed ID: 29459660)
1. Selection of GalNAc-conjugated siRNAs with limited off-target-driven rat hepatotoxicity.
Janas MM; Schlegel MK; Harbison CE; Yilmaz VO; Jiang Y; Parmar R; Zlatev I; Castoreno A; Xu H; Shulga-Morskaya S; Rajeev KG; Manoharan M; Keirstead ND; Maier MA; Jadhav V
Nat Commun; 2018 Feb; 9(1):723. PubMed ID: 29459660
[TBL] [Abstract][Full Text] [Related]
2. The Nonclinical Safety Profile of GalNAc-conjugated RNAi Therapeutics in Subacute Studies.
Janas MM; Harbison CE; Perry VK; Carito B; Sutherland JE; Vaishnaw AK; Keirstead ND; Warner G
Toxicol Pathol; 2018 Oct; 46(7):735-745. PubMed ID: 30139307
[TBL] [Abstract][Full Text] [Related]
3. Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates.
Yu M; Qin J; Liu X; Ramsden D; Williams B; Zlatev I; Guenther D; Matsuda S; Tymon R; Darcy J; Wong C; Tsung J; Zawaneh P; Chong S; Theile CS; Taneja N; Rogers A; Liu J; Castellanos-Rizaldos E; Bond S; So K; Denoncourt J; Castoreno A; Manoharan M; Wu JT; Fitzgerald K; Maier MA; Jadhav V; Nair JK
Nucleic Acids Res; 2024 Jun; 52(10):5423-5437. PubMed ID: 38742636
[TBL] [Abstract][Full Text] [Related]
4. Hepatocyte-specific delivery of siRNAs conjugated to novel non-nucleosidic trivalent N-acetylgalactosamine elicits robust gene silencing in vivo.
Rajeev KG; Nair JK; Jayaraman M; Charisse K; Taneja N; O'Shea J; Willoughby JL; Yucius K; Nguyen T; Shulga-Morskaya S; Milstein S; Liebow A; Querbes W; Borodovsky A; Fitzgerald K; Maier MA; Manoharan M
Chembiochem; 2015 Apr; 16(6):903-8. PubMed ID: 25786782
[TBL] [Abstract][Full Text] [Related]
5. Plasma Pharmacokinetics of N-Acetylgalactosamine-Conjugated Small-Interfering Ribonucleic Acids (GalNAc-Conjugated siRNAs).
Sten S; Cardilin T; Antonsson M; Gennemark P
Clin Pharmacokinet; 2023 Dec; 62(12):1661-1672. PubMed ID: 37824025
[TBL] [Abstract][Full Text] [Related]
6. Overcoming GNA/RNA base-pairing limitations using isonucleotides improves the pharmacodynamic activity of ESC+ GalNAc-siRNAs.
Schlegel MK; Matsuda S; Brown CR; Harp JM; Barry JD; Berman D; Castoreno A; Schofield S; Szeto J; Manoharan M; Charissé K; Egli M; Maier MA
Nucleic Acids Res; 2021 Nov; 49(19):10851-10867. PubMed ID: 34648028
[TBL] [Abstract][Full Text] [Related]
7. Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs.
Agarwal S; Allard R; Darcy J; Chigas S; Gu Y; Nguyen T; Bond S; Chong S; Wu JT; Janas MM
Nucleic Acid Ther; 2021 Aug; 31(4):309-315. PubMed ID: 33861634
[TBL] [Abstract][Full Text] [Related]
8. siRNA Design and GalNAc-Empowered Hepatic Targeted Delivery.
Lu M; Zhang M; Hu B; Huang Y
Methods Mol Biol; 2021; 2282():77-100. PubMed ID: 33928571
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Drug-Drug Interaction Evaluation of GalNAc Conjugated siRNAs Against CYP450 Enzymes and Transporters.
Ramsden D; Wu JT; Zerler B; Iqbal S; Jiang J; Clausen V; Aluri K; Gu Y; Dennin S; Kim J; Chong S
Drug Metab Dispos; 2019 Oct; 47(10):1183-1194. PubMed ID: 31270142
[TBL] [Abstract][Full Text] [Related]
10. A combinatorial approach for achieving CNS-selective RNAi.
Ferguson CM; Godinho BMDC; Echeverria D; Hassler M; Vangjeli L; Sousa J; McHugh N; Alterman J; Hariharan V; Krishnamurthy PM; Watts J; Rogaev E; Khvorova A
Nucleic Acids Res; 2024 May; 52(9):5273-5284. PubMed ID: 38348876
[TBL] [Abstract][Full Text] [Related]
11. Chimeric siRNAs with chemically modified pentofuranose and hexopyranose nucleotides: altritol-nucleotide (ANA) containing GalNAc-siRNA conjugates: in vitro and in vivo RNAi activity and resistance to 5'-exonuclease.
Kumar P; Degaonkar R; Guenther DC; Abramov M; Schepers G; Capobianco M; Jiang Y; Harp J; Kaittanis C; Janas MM; Castoreno A; Zlatev I; Schlegel MK; Herdewijn P; Egli M; Manoharan M
Nucleic Acids Res; 2020 May; 48(8):4028-4040. PubMed ID: 32170309
[TBL] [Abstract][Full Text] [Related]
12. Safety evaluation of 2'-deoxy-2'-fluoro nucleotides in GalNAc-siRNA conjugates.
Janas MM; Zlatev I; Liu J; Jiang Y; Barros SA; Sutherland JE; Davis WP; Liu J; Brown CR; Liu X; Schlegel MK; Blair L; Zhang X; Das B; Tran C; Aluri K; Li J; Agarwal S; Indrakanti R; Charisse K; Nair J; Matsuda S; Rajeev KG; Zimmermann T; Sepp-Lorenzino L; Xu Y; Akinc A; Fitzgerald K; Vaishnaw AK; Smith PF; Manoharan M; Jadhav V; Wu JT; Maier MA
Nucleic Acids Res; 2019 Apr; 47(7):3306-3320. PubMed ID: 30820542
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of GalNAc-siRNA Conjugate Activity in Pre-clinical Animal Models with Reduced Asialoglycoprotein Receptor Expression.
Willoughby JLS; Chan A; Sehgal A; Butler JS; Nair JK; Racie T; Shulga-Morskaya S; Nguyen T; Qian K; Yucius K; Charisse K; van Berkel TJC; Manoharan M; Rajeev KG; Maier MA; Jadhav V; Zimmermann TS
Mol Ther; 2018 Jan; 26(1):105-114. PubMed ID: 28988716
[TBL] [Abstract][Full Text] [Related]
14. Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits robust RNAi-mediated gene silencing.
Nair JK; Willoughby JL; Chan A; Charisse K; Alam MR; Wang Q; Hoekstra M; Kandasamy P; Kel'in AV; Milstein S; Taneja N; O'Shea J; Shaikh S; Zhang L; van der Sluis RJ; Jung ME; Akinc A; Hutabarat R; Kuchimanchi S; Fitzgerald K; Zimmermann T; van Berkel TJ; Maier MA; Rajeev KG; Manoharan M
J Am Chem Soc; 2014 Dec; 136(49):16958-61. PubMed ID: 25434769
[TBL] [Abstract][Full Text] [Related]
15. Advanced siRNA Designs Further Improve In Vivo Performance of GalNAc-siRNA Conjugates.
Foster DJ; Brown CR; Shaikh S; Trapp C; Schlegel MK; Qian K; Sehgal A; Rajeev KG; Jadhav V; Manoharan M; Kuchimanchi S; Maier MA; Milstein S
Mol Ther; 2018 Mar; 26(3):708-717. PubMed ID: 29456020
[TBL] [Abstract][Full Text] [Related]
16. Minimal Physiologically Based Pharmacokinetic-Pharmacodynamic (mPBPK-PD) Model of
Ayyar VS; Song D; Zheng S; Carpenter T; Heald DL
J Pharmacol Exp Ther; 2021 Nov; 379(2):134-146. PubMed ID: 34413198
[TBL] [Abstract][Full Text] [Related]
17. From bench to bedside: Improving the clinical safety of GalNAc-siRNA conjugates using seed-pairing destabilization.
Schlegel MK; Janas MM; Jiang Y; Barry JD; Davis W; Agarwal S; Berman D; Brown CR; Castoreno A; LeBlanc S; Liebow A; Mayo T; Milstein S; Nguyen T; Shulga-Morskaya S; Hyde S; Schofield S; Szeto J; Woods LB; Yilmaz VO; Manoharan M; Egli M; Charissé K; Sepp-Lorenzino L; Haslett P; Fitzgerald K; Jadhav V; Maier MA
Nucleic Acids Res; 2022 Jul; 50(12):6656-6670. PubMed ID: 35736224
[TBL] [Abstract][Full Text] [Related]
18. siRNA conjugates carrying sequentially assembled trivalent N-acetylgalactosamine linked through nucleosides elicit robust gene silencing in vivo in hepatocytes.
Matsuda S; Keiser K; Nair JK; Charisse K; Manoharan RM; Kretschmer P; Peng CG; V Kel'in A; Kandasamy P; Willoughby JL; Liebow A; Querbes W; Yucius K; Nguyen T; Milstein S; Maier MA; Rajeev KG; Manoharan M
ACS Chem Biol; 2015 May; 10(5):1181-7. PubMed ID: 25730476
[TBL] [Abstract][Full Text] [Related]
19. Investigating the pharmacodynamic durability of GalNAc-siRNA conjugates.
Brown CR; Gupta S; Qin J; Racie T; He G; Lentini S; Malone R; Yu M; Matsuda S; Shulga-Morskaya S; Nair AV; Theile CS; Schmidt K; Shahraz A; Goel V; Parmar RG; Zlatev I; Schlegel MK; Nair JK; Jayaraman M; Manoharan M; Brown D; Maier MA; Jadhav V
Nucleic Acids Res; 2020 Dec; 48(21):11827-11844. PubMed ID: 32808038
[TBL] [Abstract][Full Text] [Related]
20. The Nonclinical Disposition and Pharmacokinetic/Pharmacodynamic Properties of
McDougall R; Ramsden D; Agarwal S; Agarwal S; Aluri K; Arciprete M; Brown C; Castellanos-Rizaldos E; Charisse K; Chong S; Cichocki J; Fitzgerald K; Goel V; Gu Y; Guenther D; Habtemariam B; Jadhav V; Janas M; Jayaraman M; Kurz J; Li J; Liu J; Liu X; Liou S; Maclauchlin C; Maier M; Manoharan M; Nair JK; Robbie G; Schmidt K; Smith P; Theile C; Vaishnaw A; Waldron S; Xu Y; Zhang X; Zlatev I; Wu JT
Drug Metab Dispos; 2022 Jun; 50(6):781-797. PubMed ID: 34154993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
